Bacterial filamentation of Yersinia pestis by β-lactam antibiotics in experimentally infected mice

Archives of Pathology and Laboratory Medicine

Volumn 121, Issue 8, 1997, Pages 865-868

  Davis, Kelly J ^a   Vogel, Peter ^a   Fritz, David L ^a,b   Steele, Keith E ^a   Pitt, Margaret L ^a   Welkos, Susan L ^a   Friedlander, Arthur M ^a   Byrne, William R ^a  

^a Dept of Immunol and Molec Biology Bldg 1425 U States Army Med R   (United States)

^b UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; AZTREONAM; BETA LACTAM ANTIBIOTIC; CEFOTETAN; CEFTAZIDIME; CEFTRIAXONE;

ANTIBIOTIC SENSITIVITY; ARTICLE; CELL STRUCTURE; DRUG CHOICE; DRUG EFFECT; INTERMEDIATE FILAMENT; YERSINIA PESTIS;

ANIMALS; ANTI-BACTERIAL AGENTS; BETA-LACTAMS; FEMALE; FLAGELLA; LUNG; MICE; MICROBIAL SENSITIVITY TESTS; MICROSCOPY, ELECTRON; MORTALITY; PLAGUE; SPLEEN; YERSINIA PESTIS;

EID: 0030797536     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Bonacorsi SP, Scavizzi MR, Guiyoule A, Amouroux JH, Carniel E. Assessment of a fluoroquinolone, three β-lactams, two aminoglycosides, and a cycline in treatment of murine Yersinia pestis infection. Antimicrob Agents Chemother. 1994;38:481-486.
2. Hanberger H, Nilsson LE, Kihlström E, Maller R, Postantibiotic effect of β-lactam antibiotics on Escherichia coli evaluated by bioluminescence assay of bacterial ATP. Antimicrob Agents Chemother. 1990;34:102-106.
3. Hanberger H, Nilsson LE, Nilsson M, Maller R. Post-antibiotic of beta- lactam antibiotics on gram-negative bacteria in relation to morphology, initial killing and MIC. Eur J Clin Microbiol Infect Dis. 1991;10:927-934.
4. Comber KR, Boon RJ, Sutherland R. Comparative effects of amoxycillin and ampicillin on the morphalogy of Escherichia coli in vivo and correlation with activity. Antimicrob Agents Chemother. 1977;12:736-744.
5. Ryan DM, Monsey D. Bacterial filamentation and in vivo efficacy: a comparison of several cephalosporins. J Antimicrob Chemother. 1981;7:57-63.
6. Nakao M, Nishi T, Tsuchiya K. In vitro and in vivo morphological response of Klebsiella pneumoniae to cefotiam and cefazolin. Antimicrob Agents Chemother. 1981;19:901-910.
7. Dofferhoff ASM, Nijland JH, de Vries-Hospers HG, Mulder POM, Weites J, Bom VJJ. Effects of different types and combinations of antimicrobial agents on endotoxin release from gram-negative bacteria: an in-vitro and in-vivo study. Scand J Infect Dis. 1991;23:745-754.
8. Tomasz A. Penicillin-binding proteins and the antibacterial effectiveness of β-lactam antibiotics. Rev Infect Dis. 1986;8;S260-278.
9. Ferreira RCC, Park JT, Camelo D, De Almeida DF, Ferreira LCS. Interactions of Yersinia pestis penicillin-binding proteins with β-lactam antibiotics. Antimicrob Agents Chemother. 1995;39:1853-1855.
10. Davis KJ, Fritz DL, Pitt ML, Welkos SL, Worsham PL, Friedlander AM. Pathology of experimental pneumonic plague produced by fraction 1-positive and fraction 1-negative Yersinia pestis in African green monkeys (Cercopithecus aethiops). Arch Pathol Lab Med. 1996;120:156-163.
11. Ivins B, Fellows P, Pitt L, et al. Experimental anthrax vaccines: efficacy of adjuvants combined with protective antigen against an aerosol Bacillus anthracis spore challenge in guinea pigs. Vaccine. 1995;13:1779-1784.
12. Byrne WR, Welkos SL, Pitt ML, Friedlander AM. Antibiotic treatment of pneumonic plague in a murine model. In: Abstracts of the Thirty-sixth Interscience Conference on Antimicrobial Agents and Chemotherapy, American Society for Microbiology; September 15-18, 1996; New Orleans, La. Abstract B59.
13. Fritz DL, Jaax NK, Lawrence WB, et al. Pathology of experimental inhalation anthrax in the rhesus monkey. Lab Invest. 1995;73:691-702.
14. Lorian V, Waluschka A. Blood cultures showing aberrant forms of bacteria. Am J Clin Pathol. 1972;57:406-409.
15. Lorian V, Atkinson B. Abnormal forms of bacteria produced by antibiotics. Am J Clin Pathol. 1975;64:678-688.
16. Georgopapadakou NH, Smith SA, Sykes RB. Mode of action of azthreonam. Antimicrob Agents Chemother. 1982;21:950-956.
17. Hayes MV, Orr DC. Mode of action of ceftazidime: affinity for the penicillin-binding proteins of Escherichia coli K12, Pseudomonas aeruginosa and Staphylococcus aureus. J Antimicrob Chemother. 1983;12:119-126